Skip to main content
. 2023 Sep 19;11(9):2575. doi: 10.3390/biomedicines11092575

Figure 2.

Figure 2

Proportions of patients by study group in endoscopic remission after 14 and 54 weeks of therapy. MTX, methotrexate; AZA; azathioprine.